Consumer cost-sharing has been shown to diminish utilization of preventive services. Recent efforts, including provisions within the Affordable Care Act, have sought to increase use of preventive care through elimination of cost-sharing for clinically indicated services. We conducted a rapid review of the literature to determine the impact of cost-share elimination on utilization of preventive services. Searches were conducted in PubMed, Scopus, and CINAHL Complete databases as well as in grey literature. A total of 35 articles were included in qualitative synthesis and findings were summarized for three clinical service categories: cancer screenings, contraceptives, and additional services. Impacts of cost-sharing elimination varied depending on clinical service, with a majority of findings showing increases in use. Studies that included socioeconomic status reported that those who were financially vulnerable incurred substantial increases in utilization. Future investigations on additional clinical services are warranted as is research to better elucidate populations who most benefit from cost-sharing elimination.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/10775587211027372 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A handheld fiber-optic tissue sensing device for spine surgery.
PLoS One
December 2024
Department of Biomechanical Engineering, Faculty of Mechanical Engineering, Delft University of Technology, Delft, The Netherlands.
The demographic shift has increased the demand for surgical interventions to address age-related degenerative diseases, such as spinal fusion. Accurate placement of pedicle screws, crucial for successful spinal fusion, varies widely with physician experience. Integrating tissue sensing into spine surgical instruments allows intraoperative examination of tissue properties, providing surgeons with additional information to prevent screw misplacement.
View Article and Find Full Text PDFCost of TB care and equity in distribution of catastrophic TB care costs across income quintiles in India.
Glob Health Res Policy
December 2024
ICMR-National Institute of Epidemiology (ICMR-NIE), R-127, TNHB, Ayapakkam, Chennai, Tamil Nadu, 600077, India.
Background: Tuberculosis (TB) poses a significant social and economic burden to households of persons with TB (PwTB). Despite free diagnosis and care under the National TB Elimination Programme (NTEP), individuals often experience significant out-of-pocket expenditure and lost productivity, causing financial catastrophe. We estimated the costs incurred by the PwTB during TB care and identified the factors associated with the costs.
View Article and Find Full Text PDFFactors impacting vaccine uptake among adult Medicaid beneficiaries: a systematic literature review.
Health Aff Sch
November 2024
Merck & Co., Inc., Rahway, NJ 07065, United States.
Article Synopsis
- - Vaccine uptake among adult Medicaid beneficiaries is low, prompting a systematic review of factors influencing both patients and healthcare providers regarding vaccination practices from studies published between 2005 and 2022.
- - The review highlights that barriers to vaccination include insurance policies, cost-sharing, access to services, and the level of vaccine-related education among both patients and providers.
- - Recommendations to improve vaccination rates focus on reducing cost-sharing, enhancing educational outreach about vaccine safety and benefits, and ensuring better reimbursement rates comparable to other insurance plans.
Herpes zoster vaccination among Medicare beneficiaries with and without prescription drug coverage.
Vaccine
January 2025
Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Introduction: The Inflation Reduction Act (IRA) eliminated cost sharing for Medicare Part D-covered vaccines but did not address the cost burden faced by Medicare beneficiaries who did not have prescription drug coverage. This study aimed to determine the characteristics of beneficiaries without prescription drug coverage and to assess the association between the receipt of a herpes zoster vaccine and prescription drug coverage status.
Methods: We used the 2019-2023 National Health Interview Survey and included Medicare beneficiaries aged 65 years and older who enrolled in both Parts A and B or a Medicare Advantage plan.
Exploring patient perspectives on the impact of resuming cost sharing: a qualitative analysis.
Trials
November 2024
Department of Medicine, Cumming School of Medicine, University of Calgary, and Wellness Building 3E33, 3280 Hospital Dr. NW, TeachingCalgary, AB, Research, T2N 4Z6, Canada.
Introduction: The ACCESS trial showed that those who received a copayment elimination benefit had a modest improvement in their adherence to medications, but no improvement in clinical outcomes. This is consistent with other studies that have demonstrated that time-limited copayment elimination was welcomed by participants. However, the removal of such benefits can be problematic, as participants may have become accustomed to receiving the benefit, and made changes to their spending that would need to be reconsidered.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!